Skip to content

Evaluation of Calcium and Vitamin D in Neonates

Clinical Trial on the Evaluation of Calcium and Vitamin D in the Cord Serum of Neonates, Whose Mothers Were Under Vitamin D Treatment During Their Pregnancy

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015041321736N1
Enrollment
180
Registered
2016-01-25
Start date
2015-03-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vitamin D deficioncy. Vitamin D deficiency, unspecified

Interventions

Intervention 1: injection of 50000 units of vitamin D, eight doses every two weeks. Intervention 2: In the control group, multi natal tab including 400 units of vitamin D was taken every day.
Treatment - Drugs
injection of 50000 units of vitamin D, eight doses every two weeks
In the control group, multi natal tab including 400 units of vitamin D was taken every day.

Sponsors

Vice Chancellor of Semnan University of medical science
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: pregnant mothers with vitamin D deficiency; age of 16-35 years; singleton pregnancy; gestational age of among 8 to 12 weeks which is confirmed by LMP or sonography; BMI lower than thirty at the first prenatal visit; no history of gestational diabetes; not suffering from glycosuria, fasting blood sugar less than 92; no precedent of polyhydramnios; no history of macrosomia (weight of 4 kg) in children; with no history of stillbirth or a baby with malformations; non-smoking participants. Exclusion criteria: patients with diabetes type one or two; those with hypertension; patients with parathyroid disease and other metabolic diseases; people with untreated thyroid disease and liver or kidney deficiency; patients taking anti-epileptic drugs and corticosteroids; and people with a particular disease. Also, those who refuse consent for participating in this study, will be excluded.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
25oH vitamin D3. Timepoint: daily. Method of measurement: mg/dl.;Calcium. Timepoint: daily. Method of measurement: mg/dl.

Secondary

MeasureTime frame
-. Timepoint: -. Method of measurement: -.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Shamsollah Nouripour

Amir al-mo'menin Hospital

sh.noripour@yahoo.com+98 23 3346 0099

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026